Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia
Clinical trial NCT02445352 · COMPLETED
Trial details
- NCT number
- NCT02445352
- Sponsor
- Alvogen Korea
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-01-01
- Enrollment
- 379
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.